Moxifloxacină Misom (Moxifloxacin Hydrochloride)

Moxifloxacină Misom is a fluoroquinolone antibiotic used in the ocular pathway to manage bacterial eye infections.

• Bacterial conjunctivitis: reduces bacterial load and accelerates symptom relief in acute conjunctival infection.
• Bacterial keratitis: eradicates pathogenic bacteria in corneal ulcers, supporting healing and preventing scarring.
• Post‑operative ocular prophylaxis: prevents bacterial contamination after intra‑ocular surgery such as cataract extraction.

• Moxifloxacin Hydrochloride inhibits bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication and transcription. By binding to the quinolone‑binding site, it prevents supercoiling and relaxation of bacterial DNA, leading to rapid bactericidal activity against a broad spectrum of Gram‑positive and Gram‑negative ocular pathogens. The resulting DNA damage halts bacterial cell division, allowing the host immune system to clear the infection.

Moxifloxacină Misom may cause ocular and systemic adverse reactions, which are categorized by frequency and severity.

Common Side Effects

• Eye irritation or burning sensation
• Redness of the conjunctiva
• Foreign body sensation
• Transient blurred vision
• Increased tearing
• Mild eyelid edema

Serious or Rare Side Effects

• Allergic contact dermatitis of the eye
• Corneal ulceration or perforation
• Severe ocular pain
• Vision loss
• Stevens‑Johnson syndrome or toxic epidermal necrolysis
• Systemic hypersensitivity reactions

When prescribing Moxifloxacină Misom, clinicians should consider several safety precautions to minimize risk.

• Pregnancy: safety not established; avoid unless the benefit outweighs the risk.
• Breastfeeding: unknown excretion in milk; use with caution.
• Hypersensitivity: do not use in patients with known allergy to fluoroquinolones or any component of the formulation.
• Contact lens wearers: discontinue lens use during treatment to reduce irritation.
• Concurrent ocular steroids: monitor closely as combined use may increase risk of corneal thinning.
• Store at room temperature: keep in the original container, protect from light and moisture.

Moxifloxacină Misom can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid)

• Systemic fluoroquinolones: concurrent use may increase systemic exposure and risk of tendon or CNS toxicity.
• Anticholinergic eye drops: may reduce ocular absorption of moxifloxacin, diminishing antibacterial effect.

Moderate Interactions (Monitor Closely)

• Topical corticosteroids: combined therapy can heighten the chance of corneal ulceration.
• Non‑steroidal anti‑inflammatory eye drops: may alter corneal healing dynamics.
• Antihistamine eye drops: could increase ocular dryness, exacerbating irritation.